Company: ARTL
Filing Date: 2025-05-13
Form Type: 10-Q
Source: 0001640334-25-000825
Chunk: 122

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-05-13
Form: 10-Q
Item: Part I, Item 1
Chunk 122
---
 stock issued or outstanding. Common Shares The Company has authorized 50,000,000 shares of Common Stock with a par value of $0.001 per share. Each share of Common Stock entitles the holder to one vote, in person or proxy, on any matter on which an action of the stockholders of the Company is sought. As of March 31, 2025, and December 31, 2024, there were 3,281,032 and 3,281,032 shares of Common Stock issued and outstanding, respectively.  Warrants A summary of activity of the warrants during the three months ended March 31, 2025, is as follows:       Weighted   Weighted    Number of   Average   Average    shares  Exercise Price  Life (years) Outstanding, December 31, 2024  139,897  $11.25   0.79 Granted  -   -   - Expired  -   -   - Exercised  -   -   - Outstanding, March 31, 2025  139,897  $11.25   0.54  The intrinsic value of the warrants as of March 31, 2025, is $0. All of the outstanding warrants are exercisable as of March 31, 2025. 2018 Equity Incentive Plan, as amended On February 28, 2025, the number of shares available under the Company’s 2018 Equity Incentive Plan, as amended (the “2018 Plan”) was increased by 484,155 shares of Common Stock. As of March 31, 2025, the 2018 Plan permits the Company to issue up to an aggregate of 2,013,378 shares of Common Stock of which 1,239,773 shares are available to be issued. The following is a summary of stock option activity during the three months ended March 31, 2025:   Options Outstanding  Weighted Average   Number of  Weighted Average  Remaining life    Options  Exercise Price  (years) Outstanding, December 31, 2024  773,605  $1.84   7.76 Granted  -